Pfizer and Flynn Pharma fined GBP70m for excessive and unfair pricing after UK antitrust reassessment | Allen & Overy LLP

The UK Competition and Markets Authority (CMA) has reimposed fines on Pfizer and Flynn Pharma for abusing their dominant positions by charging excessive and unfair prices for phenytoin,...

Related Keywords

Italy ,Netherlands ,United Kingdom ,Spain ,Italian ,Dutch ,Flynn Pharma ,Andrea Coscelli ,Pfizer ,Allen Overy ,Italian Competition Authority ,European Commission ,United Kingdom Competition ,Markets Authority ,Competition Appeal Tribunal ,Executive Andrea Coscelli ,